摘要 : Abstract Treatment with the CXCR4 antagonist, plerixafor (AMD3100), has been proposed for clinical use in patients with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome and in pulmonary fibrosis. However... 展开
期刊名称 | 《Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society》 |
---|---|
总页数 | 11 |
语种/中图分类号 | 英语 / R33 |
关键词 | neutrophil activation neutrophil dynamics neutrophil mobilization |
馆藏号 | N2007EPST0002301 |